Cost-benefit analysis of surveillance for surgical site infection following caesarean section

BMJ Open
Catherine WlochTheresa Lamagni

Abstract

To estimate the economic burden to the health service of surgical site infection following caesarean section and to identify potential savings achievable through implementation of a surveillance programme. Economic model to evaluate the costs and benefits of surveillance from community and hospital healthcare providers' perspective. England. Women undergoing caesarean section in National Health Service hospitals. Costs attributable to treatment and management of surgical site infection following caesarean section. The costs (2010) for a hospital carrying out 800 caesarean sections a year based on infection risk of 9.6% were estimated at £18 914 (95% CI 11 521 to 29 499) with 28% accounted for by community care (£5370). With inflation to 2019 prices, this equates to an estimated cost of £5.0 m for all caesarean sections performed annually in England 2018-2019, approximately £1866 and £93 per infection managed in hospital and community, respectively. The cost of surveillance for a hospital for one calendar quarter was estimated as £3747 (2010 costs). Modelling a decrease in risk of infection of 30%, 20% or 10% between successive surveillance periods indicated that a variable intermittent surveillance strategy achieved higher or s...Continue Reading

References

Jun 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I KappsteinF D Daschner
Dec 13, 2001·The Journal of Hospital Infection·J ReillyL Kean
May 4, 2005·The Journal of Hospital Infection·R CoelloP Borriello
Jul 11, 2006·The Journal of Hospital Infection·A JohnsonJ Reilly
Aug 11, 2006·The Journal of Hospital Infection·S BärwolffP Gastmeier
May 18, 2007·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·H SchumacherC M Malata
Mar 27, 2009·Health Statistics Quarterly·Yuan Huang Chow, Nirupa Dattani
Apr 22, 2009·The Journal of Hospital Infection·P AstagneauUNKNOWN ISO-RAISIN Steering Group
Jan 28, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Margaret A OlsenVictoria J Fraser
Aug 3, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G De AngelisS Harbarth
Aug 20, 2010·BMC Pregnancy and Childbirth·Michelle A KealyPranee Liamputtong
Aug 27, 2011·Archives of Gynecology and Obstetrics·Joan MelendezKatrina Erskine
Apr 25, 2012·The Journal of Bone and Joint Surgery. British Volume·I S VanheganF S Haddad
Aug 4, 2012·BJOG : an International Journal of Obstetrics and Gynaecology·C WlochE Sheridan
Feb 26, 2013·American Journal of Infection Control·Katharina M D MerolliniNicholas Graves
Aug 14, 2013·American Journal of Infection Control·Suzanne CorcoranMary Cafferkey
Nov 25, 2016·British Journal of Nursing : BJN·John Tingle
Feb 1, 2017·The Journal of Hospital Infection·D J Leaper, C E Edmiston
Jun 27, 2018·The Journal of Hospital Infection·G GodboleT Lamagni
Oct 9, 2018·Zdravstveno Varstvo·Irena KlavsUNKNOWN SSI-Sur network

❮ Previous
Next ❯

Citations

Nov 11, 2020·Journal of Wound Care·Charmaine ChildsJosé Verdú-Soriano
Nov 27, 2020·International Journal of Environmental Research and Public Health·Charmaine Childs, Hora Soltani
Apr 20, 2021·Acta Obstetricia Et Gynecologica Scandinavica·Brenda F NaricePriya Madhuvrata

❮ Previous
Next ❯

Software Mentioned

Excel
Risk

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.